<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2687-0940</journal-id><journal-title-group><journal-title>Challenges in modern medicine</journal-title></journal-title-group><issn pub-type="epub">2687-0940</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.52575/2687-0940-2021-44-4-373-382</article-id><article-id pub-id-type="publisher-id">93</article-id><article-categories><subj-group subj-group-type="heading"><subject>INTERNAL DISEASES</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Assessment of the quality of life and functional state of the cardiovascular system in patients who have recovered from COVID-19&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Assessment of the quality of life and functional state of the cardiovascular system in patients who have recovered from COVID-19&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Khabchabov</surname><given-names>Rustam G.</given-names></name><name xml:lang="en"><surname>Khabchabov</surname><given-names>Rustam G.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Makhmudova</surname><given-names>Elmira R.</given-names></name><name xml:lang="en"><surname>Makhmudova</surname><given-names>Elmira R.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Abdullaev</surname><given-names>Aligadzhi A.</given-names></name><name xml:lang="en"><surname>Abdullaev</surname><given-names>Aligadzhi A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Gafurova</surname><given-names>Raziyat M.</given-names></name><name xml:lang="en"><surname>Gafurova</surname><given-names>Raziyat M.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Islamova</surname><given-names>Ummet A.</given-names></name><name xml:lang="en"><surname>Islamova</surname><given-names>Ummet A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Dzhanbulatov</surname><given-names>Murad A.</given-names></name><name xml:lang="en"><surname>Dzhanbulatov</surname><given-names>Murad A.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2021</year></pub-date><volume>44</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/journal-medicine/2021/4/373-382.pdf" /><abstract xml:lang="ru"><p>Assessing the quality of life and comparing it with the functional state of the cardiovascular system patients who have undergone COVID-19 and previously had cardiovascular diseases is an important task in understanding the real severity of their disease. The study included 121 patients, men (n&amp;nbsp;= 83) and women (n = 38), aged 41&amp;ndash;76 &amp;plusmn; 4,2 years, with the presence of cardiovascular pathology, who have been on outpatient observation for two or more years. Of 121 patients included in the study, ischemic heart disease with stable exertional angina of III&amp;ndash;IV functional class was observed in n = 43 (35,6&amp;nbsp;%), arterial hypertension in n = 55 (45,4&amp;nbsp;%), diabetes mellitus, 2 type y n = 23 (19,00&amp;nbsp;%) patients. The differences before and after the study did not have significant statistical significance (p &amp;gt; 0,05). All patients were questioned with the World Health Organization&amp;#39;s quality of life questionnaire. Other types of examination: complete blood count, biochemical blood test, including blood glucose level, blood pressure measurement with a manometer, electrocardiography, daily monitoring of ECG and blood pressure. Questioning showed that 1&amp;nbsp;month after the disease, patients with insufficient energy for daily life increased by 23,2&amp;nbsp;% (p = 0,0010). Patients dissatisfied with their state of health increased by 31,4&amp;nbsp;% (p = 0,0016), etc. Thus, the change in the status of quality of life &amp;laquo;before and after&amp;raquo; was statistically significant, p &amp;lt; 0,05. In our study, the number of patients with grade I arterial hypertension decreased by 36,0&amp;nbsp;%, respectively, increased patients with II and III degrees (19&amp;nbsp;% and 33,3). Hypertensive crisis among patients with arterial hypertension was observed in almost every third n = 21 (38,2&amp;nbsp;%). Examination of patients with exertional angina of the III&amp;ndash;IV functional class showed that the functional class decreased to I&amp;ndash;II in n = 7 (16,3&amp;nbsp;%) patients, the functional class III&amp;ndash;IV remained at the same level in n = 26 (60,5&amp;nbsp;%), and myocardial infarction developed in n = 10 (23,3&amp;nbsp;%) patients. The severity of the course of ischemic disease significantly worsened after suffering from coronavirus disease in patients with exertional angina (p = 0,0023). If we correlate the questionnaire with real laboratory and instrumental examination methods, then they are comparable, the condition of patients with cardiac and vascular pathology has worsened by almost a third, compared with the condition before the COVID-19.</p></abstract><trans-abstract xml:lang="en"><p>Assessing the quality of life and comparing it with the functional state of the cardiovascular system patients who have undergone COVID-19 and previously had cardiovascular diseases is an important task in understanding the real severity of their disease. The study included 121 patients, men (n&amp;nbsp;= 83) and women (n = 38), aged 41&amp;ndash;76 &amp;plusmn; 4,2 years, with the presence of cardiovascular pathology, who have been on outpatient observation for two or more years. Of 121 patients included in the study, ischemic heart disease with stable exertional angina of III&amp;ndash;IV functional class was observed in n = 43 (35,6&amp;nbsp;%), arterial hypertension in n = 55 (45,4&amp;nbsp;%), diabetes mellitus, 2 type y n = 23 (19,00&amp;nbsp;%) patients. The differences before and after the study did not have significant statistical significance (p &amp;gt; 0,05). All patients were questioned with the World Health Organization&amp;#39;s quality of life questionnaire. Other types of examination: complete blood count, biochemical blood test, including blood glucose level, blood pressure measurement with a manometer, electrocardiography, daily monitoring of ECG and blood pressure. Questioning showed that 1&amp;nbsp;month after the disease, patients with insufficient energy for daily life increased by 23,2&amp;nbsp;% (p = 0,0010). Patients dissatisfied with their state of health increased by 31,4&amp;nbsp;% (p = 0,0016), etc. Thus, the change in the status of quality of life &amp;laquo;before and after&amp;raquo; was statistically significant, p &amp;lt; 0,05. In our study, the number of patients with grade I arterial hypertension decreased by 36,0&amp;nbsp;%, respectively, increased patients with II and III degrees (19&amp;nbsp;% and 33,3). Hypertensive crisis among patients with arterial hypertension was observed in almost every third n = 21 (38,2&amp;nbsp;%). Examination of patients with exertional angina of the III&amp;ndash;IV functional class showed that the functional class decreased to I&amp;ndash;II in n = 7 (16,3&amp;nbsp;%) patients, the functional class III&amp;ndash;IV remained at the same level in n = 26 (60,5&amp;nbsp;%), and myocardial infarction developed in n = 10 (23,3&amp;nbsp;%) patients. The severity of the course of ischemic disease significantly worsened after suffering from coronavirus disease in patients with exertional angina (p = 0,0023). If we correlate the questionnaire with real laboratory and instrumental examination methods, then they are comparable, the condition of patients with cardiac and vascular pathology has worsened by almost a third, compared with the condition before the COVID-19.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>cardiovascular disease</kwd><kwd>exertional angina</kwd><kwd>arterial hypertension</kwd><kwd>type 2 diabetes mellitus</kwd><kwd>COVID-19</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cardiovascular disease</kwd><kwd>exertional angina</kwd><kwd>arterial hypertension</kwd><kwd>type 2 diabetes mellitus</kwd><kwd>COVID-19</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Bojczov S.A., Demkina A.E., Oshhepkova E.V., Dolgusheva Yu.A. 2021. Dostizheniya i problemy` prakticheskoj kardiologii v Rossii na sovremennom e`tape [Achievements and problems of practical cardiology in Russia at the present stage]. Kardiologiya. 59 (3): 53&amp;ndash;59.</mixed-citation></ref><ref id="B2"><mixed-citation>Ayoubkhani D., Khunti K., Nafilyan V. 2021. Epidemiology of postCOVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. BMJ Yale. 11 (5): 20&amp;ndash;31.</mixed-citation></ref><ref id="B3"><mixed-citation>De Rosa S., Spaccarotella C., Basso C. 2020. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur. Heart. J. 41 (22): 2083&amp;ndash;8.</mixed-citation></ref><ref id="B4"><mixed-citation>Devlin N.J., Brooks R. 2017. EQ-5D and the EuroQol Group: Past, Present and Future. Appl. Health Econ. Health Policy. 15 (2): 127&amp;ndash;37.</mixed-citation></ref><ref id="B5"><mixed-citation>Guzik T.J., Mohiddin S.A., Dimarco A. 2020. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 116 (10): 1666&amp;ndash;87.</mixed-citation></ref><ref id="B6"><mixed-citation>Liang W., Guan W., Chen R. 2020. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 21 (3): 335&amp;ndash;337.</mixed-citation></ref><ref id="B7"><mixed-citation>Reeder L.G., Schrama P.G., Dirken J.M. 2019. Stress and cardiovascular health: An international cooperative study &amp;ndash; I. Social Science &amp;amp; Medicine. 7 (8): 573&amp;ndash;584.</mixed-citation></ref><ref id="B8"><mixed-citation>Tal-Singer R., Crapo J.D. 2020. COPD at the Time of COVID-19: A COPD Foundation Perspective. Chronic obstructive pulmonary diseases (Miami, Fla). 7 (2): 73&amp;ndash;75.</mixed-citation></ref><ref id="B9"><mixed-citation>Tu Y., Zeng Q-C., Huang Y., Li J-Y. 2018. Percutaneous coronary intervention for acute myocardial infarction with mitral regurgitation. J. Geriatr. Cardiol. 13 (6): 521&amp;ndash;527.</mixed-citation></ref><ref id="B10"><mixed-citation>Wilder-Smith A., Freedman D.O. 2020. Isolation, quarantine, social distancing and community containment: pivotal role for oldstyle public health measures in the novel coronavirus (2019- nCoV) outbreak. J. Travel. Med. 27 (2): 41&amp;ndash;48.</mixed-citation></ref><ref id="B11"><mixed-citation>Wu Z., Mc Googan J.M. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 323 (13): 1239&amp;ndash;42.</mixed-citation></ref><ref id="B12"><mixed-citation>Ye Z.W., Jin D.Y., Wu Sh. 2020. Diagnosis, Treatment, Control and Prevention of SARS-CoV-2 and Coronavirus Disease. 36 (4): 571&amp;ndash;592.</mixed-citation></ref></ref-list></back></article>